We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01504659
Recruitment Status : Terminated (Administrative issues)
First Posted : January 5, 2012
Last Update Posted : March 16, 2017
Information provided by (Responsible Party):
Juvenile Bipolar Research Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2016
  Study Completion Date : November 2016